Hepatic Cell System for Cholestatic Toxicity Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective in vitro methodologies to assess the cholestatic hepatotoxicity potential of new chemical entities (NCEs), which is crucial for determining their safety in drug development, as they fail to accurately predict the impairment of bile flow and subsequent toxicity in vivo.
Innovation Solution
Establishing a hepatic cell system (HCS) with capacities for bile acid synthesis, transport, and regulation, exposing it to varying bile acid concentrations in the presence of candidate compounds to determine toxicity profiles and compare their potency, thereby identifying potential for systemic or hepatic toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional in vitro methods are used to screen compounds, then the screening process is simple, but the accuracy in predicting cholestatic hepatotoxicity is insufficient
Solution Approach 1:
The hepatic cell system is segmented into distinct functional components: bile acid synthesis capacity, bile acid transport capacity (including efflux and uptake), and bile acid regulation mechanisms. This segmentation allows each function to be independently assessed and optimized, improving predictive accuracy while managing system complexity through modular design
Solution Approach 2:
The hepatic cell system is designed to perform multiple functions simultaneously: it synthesizes bile acids, transports them via multiple pathways (efflux transporters like BSEP and uptake transporters like NTCP), and regulates bile acid homeostasis. This multi-functionality enables comprehensive assessment of compound effects on all critical hepatobiliary processes within a single integrated system
2Reliability
If a comprehensive hepatic cell system with multiple functions is established, then the predictive accuracy for in vivo hepatotoxicity is improved, but the time and resources required for screening increase
Solution Approach 1:
The hepatic cell system is pre-established with all necessary functional capacities (bile acid synthesis, transport, and regulation) before compound screening begins. This preliminary preparation ensures that the system is ready for immediate high-throughput screening, reducing the time required for each individual compound assessment while maintaining comprehensive functional capabilities
Solution Approach 2:
The system enables rapid assessment by changing key parameters such as bile acid concentrations and compound exposures in a controlled manner. By systematically varying these parameters across multiple compounds in parallel, the system achieves comprehensive predictive accuracy while optimizing screening throughput and reducing overall assessment time
Data Source
Figure 1A~1B
Figure 2~3
Figure 4~5
AI summary
Methods of screening a compound for susceptibility to causing systemic or hepatic toxicity, using a hepatic cell system exposed to a range of concentrations of a bile acid in the absence or presence of a compound to determine a toxicity profile. In vitro systems for predicting in vivo hepatotoxic potential of a compound are also provided, and include in vitro cultured hepatic cell systems with a capacity for bile acid synthesis, bile acid transport and bile acid regulation.